FDAnews
www.fdanews.com/articles/122247-fair-balance-adverse-event-guidance-needed-for-social-media-use-industry-says

Fair Balance, Adverse Event Guidance Needed for Social Media Use, Industry Says

November 16, 2009
Drugmakers are telling the FDA that they need specific guidance on presenting balanced risk-benefit information for products on social media such as Twitter. Drugmakers, marketing agencies and patient advocacy groups also asked for agency guidance on when social media monitoring should trigger adverse event reports at the agency’s public hearing on social media.
Washington Drug Letter